Johnson Pharmacare Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was INR 25.27 million compared to INR 32.63 million a year ago. Revenue was INR 25.27 million compared to INR 32.63 million a year ago.

Net loss was INR 12.91 million compared to net income of INR 0.967 million a year ago. Basic loss per share from continuing operations was INR 0.02. Diluted loss per share from continuing operations was INR 0.02.